Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.31
Delayed Data
As of Dec 12
 -0.09 / -3.75%
Today’s Change
1.93
Today|||52-Week Range
4.70
-27.20%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.40
Today’s open2.31
Day’s range2.31 - 2.31
Volume200
Average volume (3 months)6,799
Market cap$12.3M
Data as of 1:35pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.02-5.97%
CYANCyanotech Corp0.000.00%
IBIOIbio Inc+0.04+26.88%
ISRIsoRay Inc-0.01-1.67%
Data as of 8:00pm ET, 12/12/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts